2017 Meeting American Academy of Neurology (AAN)

World MS Day

  1. Sharing tips for #LifewithMS and events for World MS Day
  2. People around the world fundraise for Kiss Goodbye to MS campaign


  1. Leading Patient Advocacy Groups Stand Together to Oppose American Health Care Act
  2. National MS Society Disappointed with House Vote, Urges Senate to Protect Patients


  1. Molecule can help to repair myelin in mice
  2. North African ethnicity is found to be a significant predictor of fast progression
  3. Gene That Boosts Resistance to Malaria linked to Susceptibility to MS and Lupus in Sardinia
  4. Researchers uncover a molecule that promotes regeneration of myelin
  5. Combined Analysis of Previously Published HSCT/Bone Marrow Transplantation Studies
  6. Discontinuing Disease-Modifying Therapy in MS
  7. Brain Gadolinium Deposition Varies With Contrast Agent in MS
  8. Gene Variant Triggers Autoimmunity, Protects Against Malaria
  9. Vitamin D and birth month
  10. Analysis of stem cell studies

Clinical Trials

  1. Oral Ozanimod Looks Safe and Effective in Relapsing MS
  2. Ocrelizumab Benefits Early and ‘Quite Persistent’ in MS
  3. Laquinimod trial unsuccessful
  4. Laquinimod for RRMS Fails to Meet Primary Endpoint
  5. Simvastatin trial planned for secondary progressive multiple sclerosis
  6. Ozanimod trail results
  7. Biotin trial planned
  8. Multi-million pound trial to investigate if statins could become MS treatment

Treatment News

  1. First treatment licensed for primary progressive MS in the US
  2. All About Teamwork in MS
  3. Alemtuzumab: Durable Efficacy at 6 Years in MS
  4. Potential risks of common MS treatment
  5. Gilenya effect on relapses
  6. Fampridine granted full licence
  7. Safety of beta interferon
  8. Sativex in the UK
  9. Relapsing-remitting MS: Alemtuzumab boosts outcomes for black patients

General news

  1. New tool to improve disability benefits test
  2. Next UK Government must commit: no more cuts to disability benefits
  3. Rise in avoidable hospital admissions for people with MS
  4. Racial Disparities in Outpatient Neurologic Care
  5. A new manifesto for neurology services in England
  6. Contraceptive safety in MS
  7. Carers and the impact of MS
  8. MS in America
  9. Revisions Underway to McDonald Criteria on MS Diagnosis

Mental & Emotional Health

  1. Assisted suicide rethink


  1. Weight and MS severity
  2. Children, vitamin D and obesity


  1. “Planbaby bei MS” offers support and advice on starting a family to young adults with MS
  2. Smoking and MS

News posted on Barts MS Blog, with thanks to Gavin Giovannoni and his team:

  1. #BrainHealth: a brain health guide for nurses
  2. #ClinicSpeak: What does the NHS crisis mean for pe…
  3. #ClinicSpeak: developing a personal relationship w…
  4. #ClinicSpeak: delayed MS diagnosis
  5. #ClinicSpeak: Day-4 post cyberbombing
  6. #ClinicSpeak: what is CMV reactivation disease?
  7. #ClinicSpeak: are you planning to go abroad for HS…
  8. #ClinicSpeak: real world evidence teriflunomide
  9. #ClinicSpeak & #ResearchSpeak: daclizumab’s impact…
  10. #ClinicSpeak & #ResearchSpeak: Graves’ eye disease…
  11. #ClinicSpeak & #BrainHealth: do we really need to …
  12. #ClinicSpeak & #BrainHealth: policy document under…
  13. #NeuroSpeak: DMF as a second-line agent or not
  14. #NeuroSpeak: more on ocrelizumab in PPMS
  15. #NewsSpeak: Jet-lag and the CMSC 2017 meeting in N…
  16. #NewsSpeak: ECTRIMS NEWSLETTER May 2017
  17. #NewsSpeak: MS-STAT2 finally takes-off
  18. #NewsSpeak: third laquinimod trial in RRMS fails
  19. #PatientSpeak: I have primary progressive MS ……..
  20. #PlainEnglish: Targeting the “virus factory” to st…
  21. #PoliticalSpeak: on-label teriflunomide vs. off-la…
  22. #ResearchSpeak: MS is one disease
  23. #ThinkSpeak: social medicine and meat
  24. #ThinkSpeak: immune rejuvenation therapy
  25. #ThinkSpeak & #AAN2017: musings on my return from …
  26. #ThinkSpeak & #ClinicSpeak: do PPMSers need a DMT?…
  27. #ThinkSpeak & #PolitcalSpeak: a balancing act
  28. AAN-ABN
  29. AAN2017: BBC could be used to advertise……healt…
  30. T regs
  31. MS isn’t caused by antibodies to myelin
  32. Damaging Cholesterol
  33. CD20 antibodies deplete EBV
  34. First case of PML on Ocrelizumab reported
  35. GABA controls oligodendrocytes
  36. GABA and Remyelination-Its Confusing I know but no…
  37. Be A Hero Ocrevus
  38. What is your Choice?
  39. Steroids and relapse route does not matter
  40. MS Genes why they may not always cause MS
  41. Overdosing with Natalizumab
  42. Are we there yet with JCV testing?
  43. Blast from the Past…Memory B cells depleted by H…
  45. DMF kills Memory B cells
  46. Dimethyl fumarate and Memory B cells
  47. BBB permeability is formed by slow rate of movemen…
  48. Imaging T cells in real time is Grizzly
  49. How do statins work in Secondary Progressive MS
  50. New outcomes for Progressive MS in a Year
  51. Heart Failure during Relapse

©Willeke Van Eeckhoutte and Ireland, Multiple Sclerosis & Me, 2011-2017. Unauthorised use and/or duplication of this material without express and written permission from this blog’s author and/or owner are strictly prohibited. Excerpts and links may be used, provided that full and clear credit is given to WVE and Ireland, Multiple Sclerosis & Me with appropriate and specific direction to the original content.

Your thoughts?

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out / Change )

Twitter picture

You are commenting using your Twitter account. Log Out / Change )

Facebook photo

You are commenting using your Facebook account. Log Out / Change )

Google+ photo

You are commenting using your Google+ account. Log Out / Change )

Connecting to %s